Evidence map›Paper›PMID 38742909›Full record

ArticlemBio2024

Arg1 from

Desmarini Desmarini, Guizhen Liu, Henning Jessen, Bethany Bowring, Angela Connolly, Ben Crossett, Julianne Teresa Djordjevic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. EstablishingAnalytical chemistry · 2025
    Article
  5. Article
  6. Cryptococcal nutrient acquisition and pathogenesis: dining on the host.Microbiology and molecular biology reviews : MMBR · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Desmarini DesmariniCentre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Sydney, Australia.
Guizhen LiuInstitute of Organic Chemistry, University of Freiburg, Freiburg im Breisgau, Germany.
Henning JessenInstitute of Organic Chemistry, University of Freiburg, Freiburg im Breisgau, Germany.
Bethany BowringCentre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Sydney, Australia.
Angela ConnollySydney Mass Spectrometry, University of Sydney, Sydney, Australia.
Ben CrossettSydney Mass Spectrometry, University of Sydney, Sydney, Australia.
Julianne Teresa DjordjevicCentre for Infectious Diseases and Microbiology, The Westmead Institute for Medical Research, Sydney, Australia.ORCID 0000-0003-4207-4115

Funding

Deutsche Forschungsgemeinschaft (DFG) 390939984DHAC | National Health and Medical Research Council (NHMRC) 1183939
6 · The paper itself

Abstract

Inositol tris/tetrakis phosphate kinases (IP

Indexed as

Cryptococcus neoformansAnimalsCryptococcosisFungal ProteinsPhosphatidylinositol 3-KinasesVirulenceVirulence FactorsFungal ProteinsPhosphatidylinositol 3-KinasesVirulence FactorsCandida albicansCryptococcus neoformansfungiinositol polyphosphate kinaseIP3-4KmycologyPI3Kvirulence

Identifiers

PMID38742909
PMCPMC11237472

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.